Literature DB >> 19141782

What have we learned from risk-reducing salpingo-oophorectomy?

Mark H Greene, Phuong L Mai.   

Abstract

Mesh：

Year:  2009        PMID： 19141782      PMCID： PMC2639316          DOI： 10.1093/jnci/djn476

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis.

Authors:  M E Sherman; J S Lee; R T Burks; J P Struewing; R J Kurman; P Hartge
Journal:  Int J Gynecol Pathol       Date:  1999-04       Impact factor: 2.762

2.  Perceived ambiguity about screening mammography recommendations: association with future mammography uptake and perceptions.

Authors:  Paul K J Han; Sarah C Kobrin; William M P Klein; William W Davis; Michael Stefanek; Steven H Taplin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

3.  Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.

Authors:  Joan L Kramer; Isela A Velazquez; Bingshu E Chen; Philip S Rosenberg; Jeffery P Struewing; Mark H Greene
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

4.  Perceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey.

Authors:  Paul K J Han; Richard P Moser; William M P Klein
Journal:  Health Expect       Date:  2007-12       Impact factor: 3.377

5.  Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families.

Authors:  J K Tobacman; M H Greene; M A Tucker; J Costa; R Kase; J F Fraumeni
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

6.  A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.

Authors:  Mark H Greene; Marion Piedmonte; Dave Alberts; Mitchell Gail; Martee Hensley; Zoe Miner; Phuong L Mai; Jennifer Loud; Gustavo Rodriguez; Jack Basil; John Boggess; Peter E Schwartz; Joseph L Kelley; Katie E Wakeley; Lori Minasian; Stephen Skates
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

7.  Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

Authors:  Susan M Domchek; Tara M Friebel; Susan L Neuhausen; Theresa Wagner; Gareth Evans; Claudine Isaacs; Judy E Garber; Mary B Daly; Rosalind Eeles; Ellen Matloff; Gail E Tomlinson; Laura Van't Veer; Henry T Lynch; Olufunmilayo I Olopade; Barbara L Weber; Timothy R Rebbeck
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

Review 8.  Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

Authors:  Douglas A Levine; Peter A Argenta; Cindy J Yee; David S Marshall; Narciso Olvera; Faina Bogomolniy; Jamal A Rahaman; Mark E Robson; Kenneth Offit; Richard R Barakat; Robert A Soslow; Jeff Boyd
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

9.  Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.

Authors:  Joseph W Carlson; Alexander Miron; Elke A Jarboe; Mana M Parast; Michelle S Hirsch; Yonghee Lee; Michael G Muto; David Kindelberger; Christopher P Crum
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

10.  Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

Authors:  Timothy R Rebbeck; Noah D Kauff; Susan M Domchek
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.